The client required a user-friendly, dynamic health economic model to articulate the value of early medical intervention for the prevention of diabetes in at-risk patient groups .

This needed to be fully customisable with local data to allow rollout across global healthcare systems with a high incidence of pre-diabetes patients .

The health economic tool also needed to be transparent and easily communicable to payers, providing a clear demonstration of the value of early intervention​.

Develop a detailed understanding regarding the current cost of pre-diabetes/diabetes in key global healthcare systems, and the available options for current prevention/management of disease.

Development of an accessible health economic model to demonstrate the value of early medical intervention in at-risk patient groups in terms of healthcare savings and improved outcomes.

Provide a resource that can be used to create future publications on the economic case for early-intervention to prevent diabetes .

Comprehensive desk research program across global markets regarding the current cost of pre-diabetes/diabetes and available options for current prevention/management of disease.

Development of a user-friendly health economic framework to communicate to payers the economic case for early intervention in pre-diabetes, for rollout across international affiliate teams.